Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 191, Issue 2, Pages 243-255Publisher
SPRINGER
DOI: 10.1007/s10549-021-06406-1
Keywords
Breast cancer; Immunotherapy; Novel treatment strategies; Intratumoral therapy; Vaccines
Categories
Ask authors/readers for more resources
Immunotherapy has shown promising results in breast cancer treatment, but there are still many unknowns that need to be explored. Numerous ongoing studies are evaluating the safety and efficacy of immunotherapy in breast cancer.
Immunotherapy has resulted in unprecedented gains in long-term outcomes for many cancer types and has revolutionized the treatment landscape of solid tumor oncology. Checkpoint inhibition in combination with chemotherapy has proven to be effective for the treatment of a subset of advanced triple-negative breast cancer in the first-line setting. This initial success is likely just the tip of the iceberg as there is much that remains unknown about how to best harness the immune system as a therapeutic strategy in all breast cancer subtypes. Therefore, numerous ongoing studies are currently underway to evaluate the safety and efficacy of immunotherapy in breast cancer. In this review, we will discuss emerging immunotherapeutic strategies for breast cancer treatment including the following: (1) Intratumoral therapies, (2) Anti-tumor vaccines, (3) B-specific T-cell engagers, and (4) Chimeric antigen receptor T-cell therapy, and (5) Emerging systemic immunotherapy strategies. For each topic, we will review the existing preclinical and clinical literature, discuss ongoing clinical trials, and highlight future directions in the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available